DK1240164T3 - Benzazolderivater og deres anvendelse som JNK-modulatorer - Google Patents

Benzazolderivater og deres anvendelse som JNK-modulatorer

Info

Publication number: DK1240164T3
Authority: DK; Denmark
Prior art keywords: benzazole derivatives; jnk modulators; jnk; modulators; benzazole
Prior art date: 1999-12-24

Application number

DK00991229T

Other languages

English (en)

Inventor

Serge Halazy

Dennis Church

Montserrat Camps

Pascale Gaillard

Jean-Pierre Gotteland

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-24

Filing date

2000-12-20

Publication date

2004-03-01

2000-12-20 Application filed by Applied Research Systems filed Critical Applied Research Systems

2004-03-01 Application granted granted Critical

2004-03-01 Publication of DK1240164T3 publication Critical patent/DK1240164T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Immunology (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Psychology (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK00991229T 1999-12-24 2000-12-20 Benzazolderivater og deres anvendelse som JNK-modulatorer DK1240164T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99811207A EP1110957A1 (en)	1999-12-24	1999-12-24	Benzazole derivatives and their use as JNK modulators
PCT/EP2000/013006 WO2001047920A1 (en)	1999-12-24	2000-12-20	Benzazole derivatives and their use as jnk modulators

Publications (1)

Publication Number	Publication Date
DK1240164T3 true DK1240164T3 (da)	2004-03-01

Family

ID=8243214

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00991229T DK1240164T3 (da)	1999-12-24	2000-12-20	Benzazolderivater og deres anvendelse som JNK-modulatorer

Country Status (32)

Country	Link
US (2)	US7259162B2 (da)
EP (2)	EP1110957A1 (da)
JP (1)	JP4782344B2 (da)
KR (2)	KR100736012B1 (da)
CN (1)	CN1252067C (da)
AR (1)	AR029215A1 (da)
AT (1)	ATE254123T1 (da)
AU (1)	AU780241B2 (da)
BG (1)	BG65986B1 (da)
BR (1)	BR0016911A (da)
CA (1)	CA2394809C (da)
CZ (1)	CZ300984B6 (da)
DE (1)	DE60006580T2 (da)
DK (1)	DK1240164T3 (da)
EA (1)	EA007152B1 (da)
EE (1)	EE05456B1 (da)
ES (1)	ES2206351T3 (da)
HR (1)	HRP20020496B1 (da)
HU (1)	HU229625B1 (da)
IL (2)	IL150346A0 (da)
MX (1)	MXPA02006242A (da)
NO (1)	NO323146B1 (da)
NZ (1)	NZ519423A (da)
PL (1)	PL356634A1 (da)
PT (1)	PT1240164E (da)
RS (1)	RS51008B (da)
SI (1)	SI1240164T1 (da)
SK (1)	SK287546B6 (da)
TR (2)	TR200302320T4 (da)
UA (1)	UA73151C2 (da)
WO (1)	WO2001047920A1 (da)
ZA (1)	ZA200204427B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1300116C (zh)	2001-04-16	2007-02-14	卫材株式会社	1h－吲唑化合物
ES2318041T3 (es)	2001-07-23	2009-05-01	Laboratoires Serono Sa	Derivados de arilsulfonamida como inhibidores de c-jun quinasas (jnk) n-terminales.
US7776854B2 (en)	2001-12-07	2010-08-17	Merck Serono Sa	Benzazole derivatives for the treatment of scleroderma
RS51407B (sr) *	2002-04-25	2011-02-28	Laboratoires Serono Sa	Piperazinski benzotijazoli kao agensi za lečenje cerabralnih ishemičnih poremećaja ili poremećaja cns
TW200406385A (en)	2002-05-31	2004-05-01	Eisai Co Ltd	Pyrazole compound and pharmaceutical composition containing the same
US7465736B2 (en)	2002-06-14	2008-12-16	Laboratoires Serono S.A.	Azole methylidene cyanide derivatives and their use as protein kinase modulators
ES2438967T3 (es)	2002-10-23	2014-01-21	University Of Utah Research Foundation	Análisis de fusión de amplicones con colorantes de saturación
EP1633363B1 (en) *	2003-05-08	2012-11-07	Merck Serono SA	Pyridinyl acetonitriles
CA2534314C (en) *	2003-09-12	2012-11-13	Applied Research Systems Ars Holding N.V.	Benzothiazole derivatives for the treatment of diabetes
AU2004272306A1 (en) *	2003-09-12	2005-03-24	Merck Serono Sa	Benzimidazole acetonitriles
WO2005026159A1 (en) *	2003-09-12	2005-03-24	Applied Research Systems Ars Holding N.V.	Benzoxazole acetonitriles
EA017893B1 (ru) *	2004-04-08	2013-04-30	Лаборатуар Сероно Са	Композиции, содержащие ингибитор jnk и циклоспорин
US7387887B2 (en) *	2004-04-20	2008-06-17	University Of Utah Research Foundation	Nucleic acid melting analysis with saturation dyes
US9657347B2 (en)	2004-04-20	2017-05-23	University of Utah Research Foundation and BioFire Defense, LLC	Nucleic acid melting analysis with saturation dyes
US20060094753A1 (en)	2004-10-29	2006-05-04	Alcon, Inc.	Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
US7803824B2 (en)	2004-10-29	2010-09-28	Alcon, Inc.	Use of inhibitors of Jun N-terminal kinases to treat glaucoma
US7838522B2 (en)	2004-11-17	2010-11-23	Ares Trading S.A.	Benzothiazole formulations and use thereof
BRPI0517782A (pt) *	2004-11-17	2008-10-21	Ares Trading Sa	formulações de benzotiazol e uso das mesmas
BRPI0516383A (pt)	2004-12-21	2008-09-02	Serono Lab	derivados cìclicos de sulfonil amino e o uso dos mesmos
UA86862C2 (en)	2005-01-31	2009-05-25	Лаборатуар Сероно С.А.	N-hydroxyamide derivatives and use thereof
US20060223807A1 (en)	2005-03-29	2006-10-05	University Of Massachusetts Medical School, A Massachusetts Corporation	Therapeutic methods for type I diabetes
KR20080044836A (ko)	2005-07-15	2008-05-21	라보라뚜와르 세로노 에스. 에이.	자궁내막증 치료용 ｊｎｋ 억제제
BRPI0613042A2 (pt) *	2005-07-15	2010-12-14	Serono Lab	inibidores de jnk para o tratamento de endometriose
WO2007025991A2 (en)	2005-09-01	2007-03-08	Ares Trading S.A.	Treatment of optic neuritis
CA2633980A1 (en)	2005-12-29	2007-07-12	Anthrogenesis Corporation	Improved composition for collecting and preserving placental stem cells and methods of using the composition
JP2009538882A (ja) *	2006-06-02	2009-11-12	メルクセローノソシエテアノニム	皮膚疾患の治療のためのｊｎｋ阻害物質
EP2057004B1 (en) *	2006-08-28	2015-12-23	Dantherm Air Handling A/S	Method for manufacturing a heat exchanger
CN101688177A (zh)	2007-02-12	2010-03-31	人类起源公司	来自贴壁胎盘干细胞的肝细胞和软骨细胞；以及cd34+、cd45-胎盘干细胞富集的细胞群
BRPI0917634A2 (pt) *	2008-08-12	2015-11-17	Sirtris Pharmaceuticals Inc	benzoxazolas, benztiazolas e análogos relacionados como moduladores de sirtuína
EP2346856A1 (en)	2008-09-29	2011-07-27	Telik, Inc.	2-[1h-benzimidazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
AR093183A1 (es)	2010-12-31	2015-05-27	Anthrogenesis Corp	Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras
CN102199147A (zh) *	2011-03-19	2011-09-28	陕西合成药业有限公司	用于治疗的硝基咪唑衍生物
CN104220081A (zh)	2011-06-01	2014-12-17	人类起源公司	利用胎盘干细胞治疗疼痛
WO2014114186A1 (zh) *	2013-01-24	2014-07-31	山东亨利医药科技有限责任公司	Jnk抑制剂
US20160310477A1 (en) *	2013-12-20	2016-10-27	Biomed Valley Discoveries, Inc.	Cancer treatments using combinations of mek type 1 and erk inhibitors
KR101520378B1 (ko) *	2014-10-02	2015-05-26	(주)에프테크	습식 가스 스크러버의 배기유도장치
ES2751623T3 (es) *	2014-10-08	2020-04-01	Inst Nat Sante Rech Med	Nuevos compuestos de aminopiridina útiles como inhibidores de la prenilación de proteínas
JP6886165B2 (ja) *	2016-02-15	2021-06-16	国立大学法人山形大学	ガン抑制薬及び抗腫瘍剤、腫瘍再発防止剤、腫瘍発生予防剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2918369A (en) *	1956-06-15	1959-12-22	Gen Aniline & Film Corp	Non-ionic benzimidazole cyanine dyes containing in alpha-position a cyano group on the methenyl chain
GB864131A (en) *	1957-07-17	1961-03-29	Ciba Ltd	Benzimidazolyl-acetic acid derivatives
DE1963542A1 (de)	1969-12-18	1971-06-24	Siemens Ag	Koppelfeldanordnung fuer Fernmelde-,insbesondere Fernsprechanlagen
JPS51123223A (en) *	1975-04-21	1976-10-27	Fuji Photo Film Co Ltd	Process for producing condensation products
CH593954A5 (da) *	1975-07-21	1977-12-30	Ciba Geigy Ag
US4933341A (en) *	1988-10-08	1990-06-12	Bayer Aktiengesellschaft	Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
EP0364765A3 (de) *	1988-10-08	1991-07-17	Bayer Ag	Substituierte 1,3,5-Triazintrione, Verfahren zu ihrer Herstellung und ihre Verwendung gegen parasitäre Protozoen
US5523312A (en) *	1994-09-27	1996-06-04	Sterling Winthrop Inc.	Antipicornaviral agents
US6043083A (en)	1997-04-28	2000-03-28	Davis; Roger J.	Inhibitors of the JNK signal transduction pathway and methods of use
JP4153574B2 (ja) *	1997-09-10	2008-09-24	トーアエイヨー株式会社	新規なピペリジン誘導体、その製造法およびそれを含有する循環器官用剤
GB9721437D0 (en) *	1997-10-10	1997-12-10	Glaxo Group Ltd	Heteroaromatic compounds and their use in medicine

1999
- 1999-12-24 EP EP99811207A patent/EP1110957A1/en not_active Withdrawn
2000
- 2000-12-20 PT PT00991229T patent/PT1240164E/pt unknown
- 2000-12-20 CN CNB008187045A patent/CN1252067C/zh not_active Expired - Lifetime
- 2000-12-20 KR KR1020027007971A patent/KR100736012B1/ko not_active Expired - Fee Related
- 2000-12-20 MX MXPA02006242A patent/MXPA02006242A/es active IP Right Grant
- 2000-12-20 HR HR20020496A patent/HRP20020496B1/xx not_active IP Right Cessation
- 2000-12-20 EP EP00991229A patent/EP1240164B1/en not_active Expired - Lifetime
- 2000-12-20 US US10/168,718 patent/US7259162B2/en not_active Expired - Lifetime
- 2000-12-20 DK DK00991229T patent/DK1240164T3/da active
- 2000-12-20 SI SI200030254T patent/SI1240164T1/xx unknown
- 2000-12-20 SK SK898-2002A patent/SK287546B6/sk not_active IP Right Cessation
- 2000-12-20 EE EEP200200318A patent/EE05456B1/xx not_active IP Right Cessation
- 2000-12-20 TR TR2003/02320T patent/TR200302320T4/xx unknown
- 2000-12-20 EA EA200200708A patent/EA007152B1/ru not_active IP Right Cessation
- 2000-12-20 CA CA2394809A patent/CA2394809C/en not_active Expired - Lifetime
- 2000-12-20 HU HU0204557A patent/HU229625B1/hu not_active IP Right Cessation
- 2000-12-20 RS YUP-492/02A patent/RS51008B/sr unknown
- 2000-12-20 NZ NZ519423A patent/NZ519423A/en not_active IP Right Cessation
- 2000-12-20 AU AU31616/01A patent/AU780241B2/en not_active Expired
- 2000-12-20 ES ES00991229T patent/ES2206351T3/es not_active Expired - Lifetime
- 2000-12-20 DE DE60006580T patent/DE60006580T2/de not_active Expired - Lifetime
- 2000-12-20 JP JP2001549390A patent/JP4782344B2/ja not_active Expired - Lifetime
- 2000-12-20 AT AT00991229T patent/ATE254123T1/de active
- 2000-12-20 BR BR0016911-0A patent/BR0016911A/pt not_active Application Discontinuation
- 2000-12-20 UA UA2002065195A patent/UA73151C2/uk unknown
- 2000-12-20 WO PCT/EP2000/013006 patent/WO2001047920A1/en not_active Ceased
- 2000-12-20 CZ CZ20022169A patent/CZ300984B6/cs not_active IP Right Cessation
- 2000-12-20 TR TR2002/01509T patent/TR200201509T2/xx unknown
- 2000-12-20 IL IL15034600A patent/IL150346A0/xx unknown
- 2000-12-20 PL PL00356634A patent/PL356634A1/xx unknown
- 2000-12-20 KR KR1020077008852A patent/KR20070047853A/ko not_active Ceased
- 2000-12-22 AR ARP000106912A patent/AR029215A1/es active IP Right Grant
2002
- 2002-06-03 ZA ZA200204427A patent/ZA200204427B/en unknown
- 2002-06-18 BG BG106830A patent/BG65986B1/bg unknown
- 2002-06-20 IL IL150346A patent/IL150346A/en not_active IP Right Cessation
- 2002-06-21 NO NO20022997A patent/NO323146B1/no not_active IP Right Cessation
2007
- 2007-07-18 US US11/779,585 patent/US7470686B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CZ300984B6 (cs)	2009-09-30
HK1055730A1 (en)	2004-01-21
SK8982002A3 (en)	2002-10-08
HUP0204557A2 (en)	2003-05-28
YU49202A (sh)	2006-01-16
NO323146B1 (no)	2007-01-08
HRP20020496B1 (hr)	2009-03-31
TR200302320T4 (tr)	2004-01-21
EP1240164B1 (en)	2003-11-12
HUP0204557A3 (en)	2009-03-30
CZ20022169A3 (cs)	2002-09-11
DE60006580D1 (de)	2003-12-18
ATE254123T1 (de)	2003-11-15
CA2394809C (en)	2011-03-15
RS51008B (sr)	2010-10-31
BG65986B1 (bg)	2010-08-31
HRP20020496A2 (en)	2006-03-31
TR200201509T2 (tr)	2002-09-23
EE05456B1 (et)	2011-08-15
SK287546B6 (sk)	2011-01-04
CN1252067C (zh)	2006-04-19
AR029215A1 (es)	2003-06-18
EP1110957A1 (en)	2001-06-27
BR0016911A (pt)	2002-10-22
KR20070047853A (ko)	2007-05-07
PT1240164E (pt)	2004-02-27
IL150346A (en)	2010-12-30
AU780241B2 (en)	2005-03-10
WO2001047920A1 (en)	2001-07-05
US20030162794A1 (en)	2003-08-28
PL356634A1 (en)	2004-06-28
UA73151C2 (en)	2005-06-15
HU229625B1 (hu)	2014-03-28
NO20022997D0 (no)	2002-06-21
JP4782344B2 (ja)	2011-09-28
US7259162B2 (en)	2007-08-21
CA2394809A1 (en)	2001-07-05
ES2206351T3 (es)	2004-05-16
EA007152B1 (ru)	2006-08-25
EP1240164A1 (en)	2002-09-18
EA200200708A1 (ru)	2003-02-27
JP2003519142A (ja)	2003-06-17
KR20020072282A (ko)	2002-09-14
US20070259892A1 (en)	2007-11-08
US7470686B2 (en)	2008-12-30
SI1240164T1 (en)	2004-04-30
MXPA02006242A (es)	2003-01-28
CN1433414A (zh)	2003-07-30
NZ519423A (en)	2004-04-30
BG106830A (bg)	2003-02-28
KR100736012B1 (ko)	2007-07-06
EE200200318A (et)	2003-10-15
IL150346A0 (en)	2002-12-01
AU3161601A (en)	2001-07-09
ZA200204427B (en)	2004-02-03
DE60006580T2 (de)	2004-09-16
NO20022997L (no)	2002-06-21

Publication	Publication Date	Title
DK1240164T3 (da)	2004-03-01	Benzazolderivater og deres anvendelse som JNK-modulatorer
DK1204649T3 (da)	2007-12-03	Arylmethylcarbonylaminothiazolderivater og deres anvendelse som antitumormidler
NO20021253L (no)	2002-04-24	Kinolylpropylpiperidinderivater og deres anvendelse som antibakterielle midler
NO20001079L (no)	2000-09-04	Kopolymerer og deres anvendelse som borehjelpemiddel
DK1478629T3 (da)	2007-01-29	N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler
NO20020383L (no)	2002-01-24	Mutilinderivater og deres anvendelse som anti-bakterielle midler
NO20013452D0 (no)	2001-07-12	Benzoheterocykler og deres anvendelse som MEK-inhibitorer
DK1133477T3 (da)	2004-06-21	Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
NO20014702L (no)	2001-09-27	Diarylderivater og deres anvendelse som medikamenter
DK1206457T3 (da)	2004-02-16	Biaryl-oxa(thia)zolderivater og deres anvendelse som modulatorer PPAP'ER
NO20032842D0 (no)	2003-06-20	Karbazolderivater og deres anvendelse som neuropeptid Y5 reseptor ligander
DK1956004T3 (da)	2012-08-06	Quinolinderivater og deres anvendelse som 5-HT6-ligander
DK1539712T3 (da)	2008-03-17	Pyrimidinderivater og deres anvendelse som CB2-modulatorer
NO20025357D0 (no)	2002-11-08	Antranylamider og deres anvendelse som legemidler
NO20031952L (no)	2003-07-22	3-aroylinderivater og deres anvendelse som CB2 reseptoragonister
NO20025150D0 (no)	2002-10-25	2-acylindolderivater og deres anvendelse som antitumormidler
DK1161434T3 (da)	2003-05-26	Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO20044665L (no)	2004-12-03	Renzoksazin-derivater som 5-HT6-modulatorer og anvendelser derav
DK1578727T3 (da)	2008-08-04	Tetrahydroquinolin-derivater og deres anvendelse som FSH-receptor-modulatorer
NO995513L (no)	2000-01-12	N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
DK1387838T3 (da)	2006-08-14	Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
NO20001781D0 (no)	2000-04-06	3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1265892T3 (da)	2006-05-29	Isothiazolderivater og deres anvendelse som pesticider
NO20043173L (no)	2004-07-26	Benzotiazol- og benzoksazol-4,7-dionderivater og deres anvendelse som CDC25-fosfataseinhibitorer
NO20022455D0 (no)	2002-05-24	Sulfonyloksazolaminer og deres anvendelse som 5-HT6- reseptorligander